Determinants of erlotinib and pemetrexed synergism in non-small cell lung cancer (NSCLC) cell lines
Giovannetti E, Smid K, Tekle C, Mey V, Rodriguez JA, Nannizzi S, Del Tacca M, Danesi R, Giaccone G, Peters GJ
Presentation on “erlotinib-pemetrexed synergisms” at the Targeted Anticancer Agents (TAT) Meeting 2007
VUMC, Amsterdam, The Netherlands
University of Pisa, Italy
International Symposium on Targeted Anticancer Therapies (TAT 2007)
Amsterdam, 7/10 March 2007
Pdf: TAT2007
